A comprehensive view of gsk group (glaxosmithkline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GSK recalls certain Tums antacid tablets in Canada due to possible fiberglass, paper, aluminum foil contamination; recall involves Tums tablets sold in package of three rolls contain 12 tablets each distributed in Canada starting October 25
Published: December 02, 2022 by Canadian Press DataFile
European Medicines Agency accepts GSK's marketing authorization application for momelotinib for the treatment of myelofibrosis, a type of bone marrow cancer; myelofibrosis affects approximately 20,000 patients in the US
Published: December 02, 2022 by U.S. Regulated Equity Markets (Alternative Disclosure) via PUBT
Kuehne+Nagel and healthcare company GSK partner to deliver joint vaccine shipment multi-modally from Uruguay to Brazil; shipment is first of over 12 million types of doses to be distributed each year within the region, including to Argentina and Chile
Published: November 28, 2022 by Kuehne + Nagel International AG
Patent Issued for Cell culture media containing combinations of proteins (USPTO 11492389)
Published: November 28, 2022 by Biotech Business Daily
Patent Application Titled 'cGAS ANTAGONIST COMPOUNDS' Published Online (USPTO 20220356158)
Published: November 25, 2022 by Cancer Vaccine Daily

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count